| Authors: |
Vidal-Sabanés M; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain., Navaridas R; Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032, USA., Bonifaci N; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Biomedical Research Networking Center in Oncology (CIBERONC), Carlos III Health Institute (ISCIII), 28029 Madrid, Spain., Gay-Rua A; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain., Ortega-Peinado D; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain., Egea J; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain., Encinas M; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain., Matias-Guiu X; Biomedical Research Networking Center in Oncology (CIBERONC), Carlos III Health Institute (ISCIII), 28029 Madrid, Spain.; Oncologic Pathology Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain., Llobet-Navas D; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.; Biomedical Research Networking Center in Oncology (CIBERONC), Carlos III Health Institute (ISCIII), 28029 Madrid, Spain., Dolcet X; Developmental and Oncogenic Signaling Group, Department of Basic Medical Sciences, University of Lleida, Biomedical Research Institute of Lleida (IRBLleida), Lleida 25198, Lleida, Spain.; Biomedical Research Networking Center in Oncology (CIBERONC), Carlos III Health Institute (ISCIII), 28029 Madrid, Spain. |
